Association between Human Blood Metabolome and the Risk of Alzheimer's Disease.

Lulu Sun Daoxia GuoYiming JiaMengyao ShiPinni YangYu WangFanghua LiuGuo-Chong ChenYonghong ZhangZhengbao Zhu

Published in: Annals of neurology (2022)

Genetically predicted increased epiandrosterone sulfate, 5alpha-androstan-3beta-17beta-diol disulfate, and glutamine might be associated with a decreased risk of AD, while sphingomyelin was associated with an increased risk. Side-effect profiles were characterized to help inform drug target prioritization, and glutamine might be a promising target for the prevention and treatment of AD with no predicted detrimental side effects. ANN NEUROL 2022;92:756-767.

Keyphrases

endothelial cells
cognitive decline
pluripotent stem cells
combination therapy
neural network
adverse drug
smoking cessation